Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the fate of WeightWatchers, which declared bankruptcy this week, citing vastly increased use of the new blockbuster medicines.
Trending
- Who owns TikTok now and how could it change for US users?
- Acteur Alfred van den Heuvel: ‘Dertig jaar geleden werd ik ineens heel dik en ging ik anders praten’
- NHS cancer gene database to allow families to check risk
- CVC-backed Global Sport Group adds to stable with $300m Equine Network deal | Money News
- Should smartphones be locked away at gigs and in schools?
- How woman’s ‘fairytale’ home upgrade turned into a nightmare | Science, Climate & Tech News
- Barcola scores as PSG go back on top of Ligue 1
- Fans canceling World Cup tickets over ICE fears?
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
By Reuters Econ
